Serum adiponectin and HsCRP levels and non-invasive radiological methods in the early diagnosis of cardiovascular system complications in children and adolescents with type 1 diabetes mellitus

JCRPE Journal of Clinical Research in Pediatric Endocrinology

Volumn 5, Issue 3, 2013, Pages 174-181

  Gökşen, Damla ^a   Levent, Ertürk ^a   Kar, Sakine ^a   Özen, Samim ^a   Darcan, Şükran ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Adiponectin; C reactive protein; Cardiovascular diseases; Carotid intima media thickness; Type 1 diabetes mellitus

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ARTERIAL WALL THICKNESS; ARTICLE; B SCAN; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART PERFORMANCE; HEART VENTRICLE FUNCTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; TISSUE DOPPLER IMAGING;

ADIPONECTIN; ADOLESCENT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHILD; DIABETES MELLITUS, TYPE 1; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; SYSTOLE;

EID: 84884215086     PISSN: 13085727     EISSN: 13085735     Source Type: Journal    
DOI: 10.4274/Jcrpe.1003     Document Type: Article

References (45)

1. Sperling MA, Weinzimer AS, William VT. Diabetes mellitus. In: Sperling MA (ed). Pediatric Endocrinology, 3rd Ed. W.B. Saunders, Philadelphia 2008:374-421.
2. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Definition, epidemiology and classification. Pediatr Diabetes 2006;7:343-351.
3. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D'Agostino RB Sr, Wilson PW, Savage PJ. Trends in cardiovascular complications of diabetes. JAMA 2004;292:2495-2499.
4. Ross R. Aterosclerosisan inflammatory disease. N Engl J Med 1999;340:115-126.
5. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-1397.
6. Coulon J, Willems D, Dorchy H. Increase in C-reactive protein plasma levels during diabetes in infants and young adults. Presse Med 2005;34:89-93.
7. Kilpatrick ES, Keevil BG, Jagger C, Spooner RJ, Small M. Determinants of raised C-reactive protein consentration in type 1 diabetes. QJM 2000;93:231-236.
8. Karantza MV, Mittelman SD, Dorey F, Samie S, Kaiserman K, Halvorson M, Kaufman FR. Relationship of highly sensitive C-reactive protein and lipid levels in adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2008;9:122-126. Epub 2007 Nov 23
9. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-2476.
10. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y. Role of adiponectin in preventing vascular stenosis. The missing link of adipovascular axis. J Biol Chem 2002;277:37487-37491.
11. Järvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, Lehtimäki T, Rönnemaa T, Viikari J, Raitakari OT. Endothelial dysfunction and increased arterial intimamedia thickness in children with type 1 diabetes. Circulation 2004;109:1750-1755.
12. Neyzi O, Binyildiz P, Alp H. Türk çocuklarçnda büyümegelişme normlarç. I. Tartç ve boy deg̀;erleri. Ist Tçp Fak Mec 1978;41(Suppl):74.
13. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-576.
14. Sahn DJ, Demaria A, Kisslo J, Weyman A. The committee on M mode standardization of the American Society of Echocardiography Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
15. Levent E, Goksen D, Ozyurek AR, Darcan S, Coker M. Usefulness of the myocardial performance index (MPI) for assessing ventricular function in obese pediatric patients. Turk J Pediatr 2005;47:34-38.
16. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007;23:75-80. Epub 2006 Nov 14
17. Celermajer DS, Sorensen KE, Gooch VM. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-1116.
18. Giannini C, Mohn A, Chiarelli F, Kelnar CJ. Macrovascular angiopathy in children and adolescents with type 1 diabetes. Diabetes Metab Res Rev 2011;27:436-460.
19. Atabek ME, Kurtoglu S, Pirgon O, Baykara M. Arterial wall thickening and stiffening in children and adolescents with type 1 diabetes. Diabetes Res Clin Pract 2006;74:33-40.
20. Pyrzak B, Ruminska M, Popko K, Demkow U. Adiponectin as a biomarker of the metabolic syndrome in children and adolescents. Eur J Med Res 2010;15(Suppl 2):147-151.
21. Barnes MM, Curran-Everett D, Hamman RF, Maahs D, Mayer Davis EJ, D'Agostino RB Jr, West N, Dabelea D. Determinants of adiponectin levels in young people with type 1 diabetes. Diabet Med 2008;25:365-369.
22. Celi, Bini V, Papi F, Santilli E, Castellani MS, Ferretti A, Mencacci M, Berioli MG, De Giorgi G, Falorni A. Circulating adipocytokines in non-diabetic and Type 1 diabetic children: relationship to insulin therapy, glycaemic control and pubertal development. Diabet Med 2006;23:660-665.
23. Galler A, Gelbrich G, Kratzsch J, Noack N, Kapellen T, Kiess W. Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal patient. Eur J Endocrinol 2007;157:481-489.
24. Morales A, Wasserfall C, Brusko T, Carter C, Schatz D, Silverstein J, Ellis T, Atkinson M. Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care 2004;27:2010-2014.
25. Lindström T, Frystyk J, Hedman CA, Flyvbjerg A, Arnqvist HJ. Elevated circulating adiponectin in type 1 diabetes associated with long diabetes duration. Clin Endocrinol (Oxf) 2006;65:776-782.
26. Kanhai DA, Kranendonk ME, Uiterwaal CS, van der Graaf Y, Kappelle LJ, Visseren FL. Adiponectin and incident coronary heart disease and stroke.A systematic review and meta analysis of prospective studies. Obes Rev 2013;14:555-567. Epub 2013 Mar 18
27. Hao G, Li W, Guo R, Yang JG, Wang Y, Tian Y, Liu MY, Peng YG, Wang ZW. Serum total adiponectin level and the risk of cardiovascular disease in general population: A meta-analysis of 17 prospective studies. Atherosclerosis 2013;228:29-35.
28. Schöttker B, Herder C, Rothenbacher D, Roden M, Kolb H, Müller H, Brenner H. Proinflammatory Cytokines, Adiponectin, and Increased Risk of Primary Cardiovascular Events in Diabetes Patients with or without Renal Dysfunction: Results from the ESTHER Study. Diabetes Care 2013;36:1703-1711. Epub 2013 Feb 1
29. Pfützner A, Forst T. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther 2006;8:28-36.
30. MacKenzie KE, Wiltshire EJ, Peña AS, Gent R, Hirte C, Piotto L, Couper JJ. HsCRP is associated with weight, BMI, and female sex but not with endothelial function in children with type 1 diabetes. Pediatr Diabetes 2009;10:44-51. Epub 2008 Sep 15
31. Atabek ME, Pirgon O, Kurtoglu S, Imamoglu H. Evidence for an association between type 1 diabetes and premature carotid atherosclerosis in childhood. Pediatr Cardiol 2006;27:428-433.
32. Costacou T, Zgibor JC, Evans RW, Otvos J, Lopes-Virella M, Tracy RP, Orchard TJ. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Patient. Diabetologia 2005;48:41-48. Epub 2004 Dec 23
33. Enderle MD, Schroeder S, Ossen R, Meisner C, Baumbach A, Haering HU, Karsch KR, Pfohl M. Comparison of peripheral endothelial dysfunction and intima media thickness in patients with suspected coronary artery disease. Heart 1998;80:349-354.
34. Lo CS, Relf IRr, Myers KA, Wahlqvist Ml. Doppler ultrasound recognition of preclinical changes in arterial wall in diabetic subject: compliance and pulse wave damping. Diabetes Care 1986;9:27-31.
35. Kool MJ, Lambert J, Stehouwer CD, Hoeks AP, Struijker Boudier HA, Van Bortel LM. Vessel wall properties of large arteries in uncomplicated IDDM. Diabetes Care 1995;18:618-624.
36. Suys BE, Katier N, Rooman RP, Matthys D, Op De Beeck L, Du Caju MV, De Wolf D. Female children and adolescents with type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy. Diabetes Care 2004;27:1947-1953.
37. Holzmann M, Olsson A, Johansson J, Jensen-Urstad M. Left ventricular diastolic function is related to glucose in a middleaged population. J Intern Med 2002;251:415-420.
38. Shishehbor MH, Hoogwerf BJ, Schoenhagen, Marso S, Sun JP, Li J, Klein AL, Thomas JD, Garcia MJ. Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease. Am J Cardiol 2003;91:1514-1517.
39. Heilman K, Zilmer M, Zilmer, Lintrop M, Kampus P, Kals J, Tillmann V. Arterial stiffness, carotid artery intima-media thickness and plasma myeloperoxidase level in children with type 1 diabetes. Diabetes Res Clin Pract 2009;84:168-173. Epub 2009 Feb 23
40. Dalla Pozza R, Beyerlein A, Thilmany C, Weissenbacher C, Netz H, Schmidt H, Bechtold S. The effect of cardiovascular risk factors on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus. Cardiovasc Diabetol 2011;10:53.
41. Singh TP, Groehn H, Kazmers A. Vascular function and carotid intimal medial thickness in children with insulin dependent diabetes mellitus. J Am Coll Cardiol 2003;41:661-665.
42. Babar GS, Zidan H, Widlansky ME, Das E, Hoffmann RG, Daoud M, Alemzadeh R. Impaired endothelial function in preadolescent children with type 1 diabetes. Diabetes Care 2011;34:681-685.
43. Donaghue KC, Robinson J, Mccredie R, Fung A, Silink M, Celermajer DS. Large vessel dysfunction in diabetic adolescents and its relationship to small vessel complications. J Pediatr Endocrinol Metab 1997;10:593-598.
44. Wiltshire EJ, Gent R, Hirte C, Pena A, Thomas DW, Couper JJ. Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes. Diabetes 2002;51:2282-2286.
45. Shivalkar B, Dhondt D, Goovaerts I, Van Gaal L, Bartunek J, Van Crombrugge P, Vrints C. Flow mediated dilatation and cardiac function in type 1 diabetes mellitus. Am J Cardiol 2006;97:77-82. Epub 2005 Nov 16